The traumatic segment by wound type is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Single-Use Negative Pressure Wound Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Wound Type, End User and Country.” The North America single use negative pressure wound therapy market is expected to reach US$ 449.90 million by 2028 from US$ 256.18 million in 2021; it is estimated to grow at a CAGR of 8.4% from 2021 to 2028. The report highlights trends prevailing in the North America single-use negative pressure wound therapy market and the factors driving market along with those that act as hindrances. 

The North America single-use negative pressure wound therapy devices market, based on the wound type was segmented into surgical, traumatic, diabetic foot, sports injuries, venous leg ulcers, and others. The North America single-use negative pressure wound therapy devices market, based on the end user was segmented into hospitals, clinics, ambulatory surgical centers, and others. Geographically, the North America single use negative pressure wound therapy market can be sub-segmented into U.S. Mexico and Canada.

Cardinal Health Inc, ConvaTec Group Plc, Carilex Medical, Genadyne Biotechnologies, Inc., H and R Healthcare, Lohmann & Rauscher GmbH & Co. KG, Medela AG, Mölnlycke Health Care AB, PAUL HARTMANN AG, and Smith & Nephew are among the leading companies operating in the North America single-use negative pressure wound therapy market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com